Mineralys Therapeutics (MLYS) Retained Earnings (2022 - 2026)
Quarterly results put Retained Earnings at -$496.5 million for Q1 2026, down 44.04% from a year ago — trailing twelve months through Mar 2026 was -$496.5 million (down 44.04% YoY), and the annual figure for FY2025 was -$457.2 million, down 51.12%.
Mineralys Therapeutics has reported Retained Earnings over the past 5 years, most recently at -$496.5 million for Q1 2026.
- Retained Earnings reached -$496.5 million in Q1 2026 per MLYS's latest filing, down from -$457.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$52.8 million in Q4 2022 and bottomed at -$496.5 million in Q1 2026.
- Median Retained Earnings over the past 5 years was -$225.4 million (2024), compared with a mean of -$245.8 million.
- The largest annual shift saw Retained Earnings crashed 154.12% in 2024 before it tumbled 44.04% in 2026.
- Over 5 years, Retained Earnings stood at -$52.8 million in 2022, then crashed by 136.14% to -$124.7 million in 2023, then plummeted by 142.58% to -$302.5 million in 2024, then tumbled by 51.12% to -$457.2 million in 2025, then decreased by 8.6% to -$496.5 million in 2026.
- Business Quant data shows Retained Earnings for MLYS at -$496.5 million in Q1 2026, -$457.2 million in Q4 2025, and -$424.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 36.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 130.89 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | -496.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -496.51 Mn |
| Dec 31, 2025 | -457.17 Mn |
| Sep 30, 2025 | -424.90 Mn |
| Jun 30, 2025 | -388.00 Mn |
| Mar 31, 2025 | -344.70 Mn |
| Dec 31, 2024 | -302.52 Mn |
| Sep 30, 2024 | -253.57 Mn |
| Jun 30, 2024 | -197.20 Mn |
| Mar 31, 2024 | -156.20 Mn |
| Dec 31, 2023 | -124.71 Mn |
| Sep 30, 2023 | -100.32 Mn |
| Jun 30, 2023 | -77.60 Mn |
| Mar 31, 2023 | -65.40 Mn |
| Dec 31, 2022 | -52.81 Mn |